Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Ramathibodi Hospital.
Recruitment status was  Active, not recruiting
Study NCT00851461   Information provided by Ramathibodi Hospital

First Received on February 25, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Spinobulbar Muscular Atrophy
Kennedy's Disease
Additional conditions recognized in this trial
Atrophy
Bulbo-Spinal Atrophy, X-Linked
Muscular Atrophy
Muscular Disorders, Atrophic
More general conditions related to this trial
Central Nervous System Diseases
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Heredodegenerative Disorders, Nervous System
Motor Neuron Disease
Muscular Atrophy, Spinal
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurologic Manifestations
Neuromuscular Diseases
Neuromuscular Manifestations
Pathological Conditions, Anatomical
Signs and Symptoms
Spinal Cord Diseases
Interventions listed in this trial
Goserelin
Electrophysiologic study
tissue biopsy
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Ramathibodi Hospital
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services